Figure 2From: The cost effectiveness of teriparatide as a first-line treatment for glucocorticoid-induced and postmenopausal osteoporosis patients in Sweden One-Way Sensitivity Analysis Tornado Diagram: Teriparatide vs. Bisphosphonate ICERs for the PMO T −3.0/2 Fracture Cohort. Back to article page